Tentamen (uitwerkingen)
RAC 2023 US RAC Practice Exam – Questions/Answers
- Vak
- Instelling
RAC 2023 US RAC Practice Exam – Questions/Answers
[Meer zien]Voorbeeld 4 van de 35 pagina's
Voorbeeld 4 van de 35 pagina's
In winkelwagen
Voorbeeld van de inhoud
RAC 2023 US RAC Practice Exam – Questions/AnswersA physician reports to a manufacturer that a patient was hospitalized with acute sepsis after treatment with an approved device. This side effect is not listed in the package insert. This event must be reported by the manufacturer to FDA no later than:
A. 5 calendar days.
B. 15 calendar days.
C. 30 calendar days.
D. The next quarterly or annual report. - ✔ Explanation:
B. There are no 15 day reports included in MDR regulations. 15 Day reports are required b by drug reporting regulations.
The correct answer is: C
Under the IDE regulation, all of the following must be reported to the sponsor within five working days
EXCEPT:
A. A deviation from the investigational plan.
B. Withdrawal of IRB approval.
C. An unanticipated adverse device effect. D. Use of a device without informed consent. - ✔ Explanation:
B. Withdrawal of IRB approval is reported within five days.
The correct answer is C.
When design verification testing is being performed by a manufacturer, which
element is NOT included as a potential requirement under device design verification section of the QSR?
A. Identification of the design
B. Software validation
C. Identification of test methods used. D. Name of individuals performing the testing . - ✔ Explanation:
B. Software validation is generally included in design validation, not verification (820.30 (g)). The correct answer is C.
Under the statutory violations, lack of an approved PMA for a PMA device that is not exempt and is in commercial distribution is considered to be:
A. Adulteration.
B. Improper use.
C. Misbranded.
D. Fraudulent. - ✔ Explanation: D. PMA products introduced into commercial distribution without an approval
PMA are considered to be adulterated. FD&C Act 501 (f).
The correct answer is A.
A manufacturer of the following must file an IDE before conducting a human clinical study?
A. A device in commercial distribution before 28 May 1976 when used or investigated in accordance with its indications in labeling in effect at that time.
B. A device intended solely for veterinary use.
C. A custom device being studied for safety and effectiveness.
D. A device in commercial distribution before 28 May 1976 when used or investigated in accordance with its indications in labeling in effect at that time.
And a device intended solely for veterinary use. - ✔ Explanation:
C. While a custom device may be studied in humans without an IDE, if its safety and efficacy are being studied
in support of commercial marketing, an IDE must be file (21 CFR 812.2(c)(7))
The regulatory affairs professional performs all of the following prior to submitting a PMA to FDA
EXCEPT:
A Preparing criteria for the MDR report. B. Preparing a brief statement of reasons for noncompliance with regulation.
C. Identifying all omissions in PMA content.
D. Reviewing, organizing and checking adequacy of data pertaining to safety and efficacy evaluation. - ✔ Explanation:
B. This item is required by 814.20(b)
The correct answer is A
Which of the following sections is required in a PMA? A. Patent certification information.
B. A copy of quality manual.
C. An economic cost/benefit assessment.
D. A discussion of benefit and risk considerations. - ✔ Explanation:
D. See 21 CFR 814.20(b)(3)(vi)
D. A discussion of benefit and risk considerations
Subacute toxicity testing should be performed:
A. In two rodent species. B. In one rodent and one non-rodent species.
C. For a minimum of two weeks.
D. For a minimum of six months. - ✔ Explanation:
B. See ICH guideline M3 Maintenance of The ICH Guideline on Non-Clinical Safety Studies for The
Conduct of Human Clinical Trials for Pharmaceuticals.
B. In one rodent and one non-rodent species.
What FDA clearances are required to export a drug approved by FDA?
A. Certificate of Free Sale.
B. Customs Tax Stamps.
C. No clearance required.
D. FDA receipt for sample Form-484. - ✔ Explanation:
C. There are no FDA export requirements for approved products.
C. No clearance required.
Fully quality-assured individual toxicology reports are not required for submission of an initial IND application. However, finalized and fully quality assured reports should be available to FDA upon request within what period of the start of the human study?
A 90 days.
B. 120 days.
C. One year.
D. The final report is only required in the submission for the NDA - ✔ Explanation:
A See FDA "Guidance for Industry Q & A: Content and Format of INDs for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-Derived Products." OctoBer 2000.
The correct answer is B.
With respect to drug product distribution procedures, a distributor is required to do all of the following EXCEPT:
A. Establish a system whereby the oldest approved stock of a drug is distributed last.
B. Establish written procedures describing the distribution of drug products.
C. Establish a system whereby the oldest approved stock of a drug is distributed first.
D. Establish a system by which the distribution of each lot of drug product can be readily determined to facilitate its recall if necessary. - ✔ Explanation:
A. According to §211.150, this is not required of a distributor since this way of rotating stock would potentially allow a drug product to expire in storage while awaiting distribution.
The correct answer is A.
Because of reported dispensing errors due to the similarity of proprietary drug names, one of the companies involved has decided to quickly and voluntarily notify physicians and others responsible for providing patient care
about the issue via a "Dispensing Error Alert". In this approach, the company is NOT required to:
A. Use first class mail and number 10 white envelopes.
B. Use appropriate language on the outside of the mailing envelope that indicates the nature of the alert.
C. Notity FDA of its action prior to disseminating the dispensing alert notification.
D. Include its name and address in the upper left hand corner of the envelope. - ✔ Explanation:
Reference 21CFR §200.5.
The correct answer is C.
A regulatory affairs professional wants to schedule a pre-NDA meeting with the FDA. He or she should:
Dit zijn jouw voordelen als je samenvattingen koopt bij Stuvia:
Bewezen kwaliteit door reviews
Studenten hebben al meer dan 850.000 samenvattingen beoordeeld. Zo weet jij zeker dat je de beste keuze maakt!
In een paar klikken geregeld
Geen gedoe — betaal gewoon eenmalig met iDeal, creditcard of je Stuvia-tegoed en je bent klaar. Geen abonnement nodig.
Direct to-the-point
Studenten maken samenvattingen voor studenten. Dat betekent: actuele inhoud waar jij écht wat aan hebt. Geen overbodige details!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper LeCrae. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor $19.99. Je zit daarna nergens aan vast.
Is Stuvia te vertrouwen?
4,6 sterren op Google & Trustpilot (+1000 reviews)
Afgelopen 30 dagen zijn er 65040 samenvattingen verkocht
Opgericht in 2010, al 15 jaar dé plek om samenvattingen te kopen
Laatst bekeken door jou
Tentamen (uitwerkingen) ·
FMF STUDY GUIDE 2023/2024 updated to pass
Tentamen (uitwerkingen) ·
Macroeconomics 6th Canadian Edition - Test Bank.
Voordeelbundel ·
Army-Promotion Board Packaged Exams 2024/2025
Tentamen (uitwerkingen) ·
ATI Mental Health Proctored 2019 updated
Tentamen (uitwerkingen) ·
MTTC - LEARNING DISABILITIES (PRACTICE TEST)
Tentamen (uitwerkingen) ·
NUR 235 Exam 2 (Study Guide) 2022 Graded A+
Samenvatting ·
samenvatting stofwisseling en hormonen 1
Samenvatting ·
Samenvatting ethiek (vak ethiek en beleid)
